Page last updated: 2024-12-06

buquineran

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

buquineran: cardiac stimulant; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71953
CHEMBL ID26984
SCHEMBL ID783795
MeSH IDM0059915

Synonyms (22)

Synonym
uk-14275
bdpu
buquineran
1-butyl-3-(1-(6,7-dimethoxyquinazolin-4-yl)piperidin-4-yl)urea
buquineranum [inn-latin]
1-butyl-3-(1-(6,7-dimethoxy-4-quinazolinyl)-4-piperidyl)urea
urea, 1-butyl-3-(1-(6,7-dimethoxyquinazolin-4-yl)piperidin-4-yl)-
urea, n-butyl-n'-(1-(6,7-dimethoxy-4-quinazolinyl)-4-piperidinyl)-
brn 0717450
CHEMBL26984
1-butyl-3-[1-(6,7-dimethoxyquinazolin-4-yl)piperidin-4-yl]urea
59184-78-0
buquineran [inn:ban]
unii-awc1vms3hc
buquineranum
awc1vms3hc ,
5-25-13-00341 (beilstein handbook reference)
buquineran [inn]
buquineran [mart.]
SCHEMBL783795
DTXSID30207924
Q27274151
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID40531Positive inotropic effects by direct or indirect beta-1 adrenergic receptor activation.1987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
In search of the digitalis replacement.
AID220009Inhibition of cAMP Phosphodiesterase enzyme.1987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
In search of the digitalis replacement.
AID218884Electrophysiological activity as concentration causing 20 % increase in the functional refractory period of canine ventricular muscle.1987Journal of medicinal chemistry, Aug, Volume: 30, Issue:8
Cardiotonic agents. 1. Novel 8-aryl-substituted imidazo[1,2-a]- and -[1,5-a]pyridines and imidazo[1,5-a]pyridinones as potential positive inotropic agents.
AID219073Inotropic activity as dose required to cause 20% positive or negative change in contractile force of papillary muscle from ferret1987Journal of medicinal chemistry, Aug, Volume: 30, Issue:8
Cardiotonic agents. 1. Novel 8-aryl-substituted imidazo[1,2-a]- and -[1,5-a]pyridines and imidazo[1,5-a]pyridinones as potential positive inotropic agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (83.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.68 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (8.33%)5.53%
Reviews3 (25.00%)6.00%
Case Studies1 (8.33%)4.05%
Observational0 (0.00%)0.25%
Other7 (58.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]